Practical Guide to Hot-Melt Extrusion: Continuous Manufacturing and Scale-up

Similar documents
Pharma & Food Solutions. ETHOCEL One of the Few Water-Insoluble Polymers Approved for Global Pharmaceutical Applications

Figure 1. Standard spray congealing setup.

Computation of Solubility parameters using Molecular. dynamics simulation

The objective of this study was to investigate solid dispersions (SDs) of poorly water soluble drug carbamazepine (CBZ),

Quantitation of amorphous content

Product Quality Control of a HME Co-Extrudate Using a Raman Imaging Microscope

Application Note. Introduction. Analysis of crystal polymorphism by Raman Spectroscopy for Medicine Development

METHOCEL. TM Trademark of The Dow Chemical Company ( Dow ) or an affiliated company of Dow

1/31/ Plastics Processing. Thermoplastics (Tampere)

Approaches to the formulation of poorly soluble drugs

POLY(LACTIC ACID) BASED SINGLE COMPOSITES

Advances in Twin Screw Compounding Technology

NISSO HPC for Pharmaceutical Applications

Functionalized Calcium Carbonate (FCC) FCC: Newly developed structured minerals as multifunctional excipients

PREPARED BY: DR. RAHIMAH OTHMAN FOOD ENGINEERING (ERT 426) SEMESTER 1 ACADEMIC SESSION 2016/17

Recent Advances in Oral Granules and Bi-Layer Tablet Technologies, Solubility Enhancement Solutions, and Oral Disintegrating Tablet Applications

Improving Oral Bioavailability by Solid Dispersions: An OSPHENA (Ospemifene) Case Study

International Journal of Pharma and Bio Sciences DEVELOPMENT OF ACCELERATED STABILITY PROTOCOL FOR SILDENAFIL TABLETS A EUROPEAN PERSPECTIVE REVIEW

MiniLab-Compounder and Reactor

Design and Dosage Form. Dr. Deny Susanti

Calcium Carbonate in Blown HDPE Film

TEST PROCEDURES AND ACCEPTANCE CRITERIA FOR NEW VETERINARY DRUG SUBSTANCES AND NEW MEDICINAL PRODUCTS: CHEMICAL SUBSTANCES

PLASTICS. Characterization and Failure Analysis of.

On-Demand Manufacturing of Pharmaceuticals

Eudragit. Setting benchmarks in oral solid dosage forms since 1954.

GUIDANCE FOR INDUSTRY ON FIXED DOSE COMBINATIONS (FDCs)

Solubility of Solid Dispersions of Pizotifen Malate and Povidone

Dow Pharma Solutions. ETHOCEL High Productivity (HP) Polymers Safe. Fast. Efficient.

NOVEL DRUG DELIVERY SYSTEMS II

A practical computational tool to predict formulation and process variables during the development of spray-dried amorphous solid dispersions.

MASTER FILE PROCEDURES

EXTRUSION TECHNOLOGY. Extruders and extrusion lines

Public Assessment Report. Scientific discussion. Lacidipine Double-e Pharma 2 mg, 4 mg and 6 mg film-coated tablets. (lacidipine)

Roller Compaction: New trends, challenges and solutions

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH AND BIO-SCIENCE

Kollidon SR: A polyvinyl acetate based excipient for DCsustained-release

OSDrC OptiDose : A Revolution in Drug Formulation Technology

Balancing the time, cost and risk of drug development. Christina Gustafsson, PhD Pharm, Formulation Scientist at Pharmaceutical Development, APL

PROCESS ECONOMICS PROGRAM

Injection Moulding and Heat Treatment of Ni-Cr-Si-B Alloy Powder

Micophotometric Control of Particles and Inhomogeneities in Flowing Polymer Melts during Extrusion Processing

DIRECTLY COMPRESSIBLE MEDICATED CHEWING GUM (MCG) FOR STAYING ALERT

Chapter TYPE OF EXTRUDERS AND EXTRUSION CONDITIONS

Table of Contents. Robert A. Malloy. Plastic Part Design for Injection Molding. An Introduction ISBN:

WHO GUIDELINE Stability testing of active pharmaceutical ingredients and finished pharmaceutical products

Laser Welding of Engineering Plastics

Application of Quality by Design in formulation and process Development

Pharma Ingredients & Services. Ludiflash. Technical Information

Investigating Differences in Solubility Between Crystalline and Amorphous Forms of Pharmaceuticals

How to Analyze Polymers Using X-ray Diffraction

Influence of different solvents on crystal property and solubility characteristics of Carbamazapine

Additive and Colour Preparations. for Extruded Polystyrene Foams

Modeling and simulation of drug release through polymer hydrogels. Shantanu Maheshwari, Sivakumar Cherlo, Rama Subba Thavva and Venkataramana Runkana

Pharmaceutical Formulation Development of Peptides and Proteins

Final Year Project Proposal 1

Stability Report. Stability profile of. BIWG 98 SE tablets 40 mg SR of 133. This stability report comprises 133 pages.

Pharmaceutical eutectics : characterization and evaluation of tolbutamide and haloperidol using thermal analytical and complementary techniques

SOLVING ADHESION AND DIE BUILDUP PROBLEMS IN EXTRUSION COATING

Colour and Additive Preparations. for Extruded Polyolefin Foams

BIODEGRADATION KINETICS OF BIOPOLYMERS AND BIOCOMPOSITES

O RAL. Tablets HANDBOOK OF PHARMACEUTICAL VOLUME I - Part ONE. Immediate Release GENERIC DEVELOPMENT

Formulation and in vitro evaluation of bosentan osmatic controlled release tablets

ICH Topic M 4 Q Location issues for Common Technical Document for the Registration of Pharmaceuticals for Human Use Quality Questions and Answers

Packaging technology. Fundamentals, materials and processes. Edited by. Anne Emblem and Henry Emblem WOODHEAD PUBLISHING

Chemical Foaming Alternatives to Azodicarbonamide

zahnrad_neu_gb :46 Uhr Seite 1 Gear Pumps

Abstract. Technical Aspects. Applying GastroPlus for Extensions of Biowaivers for BCS Class II Compounds 2

COMPARISON STUDY OF GRINDING AND SLURRY METHOD ON PHYSICOCHEMICAL CHARACTERISTIC OF ACYCLOVIR SUCCINIC ACID COCRYSTAL

Extrusion. Key Issues to Address. Lecture 2. Process. Process Variants. Process Analysis. Problem Solving

MATERIAL SAFETY DATA SHEET

How to Identify Critical Quality Attributes and Critical Process Parameters

Guideline on the chemistry of active substances for veterinary medicinal products


Mr. Amit Ray Executive Director-Packaging Division Uflex Pvt. Ltd.

Preparation of Cefpodoxime Proxetil - Polymeric Microspheres by the Emulsion Solvent Diffusion Method for taste masking

Material Safety Data Sheet

Biowaiver Approaches for Generic Drug Products in the US: Case Studies

PARALOID EXL 2314 Impact Modifier

Microcrystalline Cellulose, Colloidal Silicon Dioxide, Sodium Starch Glycolate, Sodium Stearyl Fumarate

Transdermal Drug Delivery System Regulatory Requirements (USA)

MAKING PROPERTIES AND PROFITS

Quality Control Using X-Ray Diffraction Spectroscopy on the Degree of Crystallinity of Microcrystalline Cellulose Produced from Sugarcane Residue.

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS NOTE FOR GUIDANCE:

RHEOLOGICAL PROPERTIES ROSAND RH7 & RH10 RHEOLOGICAL INSTRUMENTS BACKED WITH RHEOLOGICAL EXPERIENCE

Effective troubleshooting of extrusion problems

Effect of Formulation and Process Variables

Outline CLINICALLY RELEVANT SPECIFICATIONS. ISPE Process Validation Conference September 2017 Bethesda, MD

LEGAL REQUIREMENTS FOR STABILITY

Reflection paper on the dissolution specification for generic solid oral immediate release products with systemic action

PHARMACEUTICAL TESTING

Roller compactors for the pharmaceutical industry. BT 120 Pharma WP 120 Pharma WP 150 Pharma WP 200 Pharma

Solid Dispersions for Oral Administration: An Overview of the Methods for their Preparation

BCS Guidance and Biowaivers BCS Monographs

Legal Notice copyright 2015 Romaco Innojet GmbH

P. Pereira, C. N. Barbosa, J. C. Viana. University of Minho, Portugal

FURTHER DETAIL FROM DSC THERMOGRAMS

Tensile Properties and FTIR Analysis of HDPE/ Soya Spent Powder in Oven Aging

USP Hypromellose Phthalate

New Developments in Moisture Barrier Materials and Conductive Adhesives for Flexible Display Applications

dear reader: Solubilization as a solution to the challenges facing the pharma industry

Transcription:

Practical Guide to Hot-Melt Extrusion: Continuous Manufacturing and Scale-up Editor: Mohammed Maniruzzaman (C(%SM1THERS R A P R A A Smithers Group Company Shawbury, Shrewsbury, Shropshire, SY4 4NR, United Kingdom Telephone: +44 (0)1939 250383 Fax: +44 (0)1939 251118 http://www.polymer-books.com

CenB Preface Contents Contributors iii vii xv 1 Introduction to Hot-Melt Extrusion, Continuous Manufacturing: Scale-up via Hot-Melt Extrusion 1 1 Background 1 1.1 Introduction 1 1.1.1 Hot-Melt Extrusion Process Technology 2 1.1.2 Equipment 3 1.1.3 Benefits and Drawbacks to Hot-Melt Extrusion 4 1.1.4 Application of Hot-Melt Extrusion 5 1.1.5 Materials used in Hot-Melt Extrusion Processes 6 1.1.6 Development of Sustained-release Formulations 7 1.1.7 Marketed Products 7 1.2 Continuous Manufacturing 8 1.3 Scale-up via Hot-Melt Process 10 1.3.1 Case Study: Scale-up of a Hot-Melt Extrusion Process using Soluplus as Carrier 11 1.4 Conclusions 14 References 15 2 Hot-Melt Extrusion as Continuous Manufacturing Technique, Current Trends and Future Perspectives 19 2.1 Hot-Melt Extrusion as Continuous Manufacturing Technique 19 2.1.1 Hot-Melt Extrusion Equipment 21 2.1.2 Single-screw Extruder 24 vii

Practical Guide to Hot-Melt Extrusion: Continuous Manufacturing and Scale-up 2.1.3 Twin-screw Extruders 24 2.1.4 Role of Glass Transition Temperature 26 2.1.5 Role of Mechanical Parameters 26 2.1.6 Use of Plasticisers or Surfactants 26 2.1.7 Challenges and Opportunities 26 2.2 Background Information on Batch Processing 27 2.2.1 Past and Future Trends of Continuous Manufacturing 28 2.2.2 Conventional Batch Process Design 29 2.2.3 Production Parameters 29 2.2.4 Production Parameters in Batch Processing 29 2.2.4.1 Active Pharmaceutical Ingredient(s) Manufacturing Site 29 2.2.4.2 Formulation Development 29 2.2.4.3 Industrial Scale-up 30 2.2.4.4 Regulatory Guidelines 30 2.2.5 Validation of Batch Processing 30 2.2.6 In-line Continuous Monitoring Techniques 30 2.3 Assimilation of Complete Quality-by-Design Models 35 2.3.1 Chief Modification in Procedural Expertise for Continuous Manufacturing 35 2.3.2 Process Parameters for Preformulation for Hot-Melt Extrusion 36 2.3.3 Implementation of a New Product Development Process 36 2.3.3.1 Modelling Simulation of Hot-Melt Extrusion Process 36 2.3.4 Flow Chart Model for Continuous Hot-Melt Extrusion based Pharmaceutical Manufacturing Process 39 2.3.5 Foremost Alteration in Structural Provisions for Quality and Technical Operations 41 2.3.6 Potential Benefits of Continuous Hot-Melt Extrusion Manufacturing 44 2.3.7 Regulatory Issues Related to Hot-Melt Extrusion 44

Contents 2.3.8 Process Analytical Technology Framework 45 2.4 Conclusion 46 References 47 3 Co-extrusion as a Novel Approach in Continuous Manufacturing Compliance 53 3 Background 53 3.1 Introduction 53 3.2 Applications of Co-extrusion via Hot-Melt Extrusion in Continuous Manufacturing 54 3.2.1 Problem Encountered During Co-extrusion 55 3.2.2 Variation of the Die Temperature 55 3.2.3 Swelling of the Die 55 3.2.4 Viscosity Matching 56 3.2.5 Adhesion 56 3.2.6 Inter diffusion 56 3.2.7 Delamination 57 3.3 Pharmaceutical Applications 57 3.3.1 Pharmaceutical Significance of the Co-extrusion Technique 57 3.4 Case Study 58 3.5 Conclusions 59 References 59 4 Solid-state Engineering of Drugs using Melt Extrusion in Continuous Process 63 4 Introduction 63 4.1 Dissolution Enhancement 63 4.1.1 Use of Novel Inorganic Excipients 63 4.1.2 Use of Polymers to Enhance Dissolutions of Poorly Water-soluble Active Pharmaceutical Ingredients 67 4.1.3 Continuous Co-crystallisation Engineering 68 4.1.4 Polymorphic Transformations via Hot-Melt Extrusion 69 ix

Practical Guide to Hot-Melt Extrusion: Continuous Manufacturing and Scale-up 4.1.4.1 Polymorphic Transformation of Carbamazepine 70 4.1.4.2 Polymorphic Transformation of Artemisinin 70 References 71 5 Continuous Co-crystallisation of Poorly Soluble Active Pharmaceutical Ingredients to Enhance Dissolution 75 5.1 Introduction 75 5.2 Mechanism of Continuous Co-crystallisation by Twin-screw Extrusion 79 5.2.1 Eutectic-mediated Co-crystallisation 80 5.2.1.1 Ibuprofen-Nicotinamide Case 80 5.2.1.2 Carbamazepine-Saccharin Case 81 5.2.2 Solvent-assisted Co-crystallisation 85 5.2.3 Amorphous Phase-mediated Co-crystallisation 87 5.2.3.1 AMG 517-Sorbic Acid Case 87 5.3 Critical Parameters Influencing Continuous Co-crystallisation by Twin-screw Extrusion 89 5.3.1 Processing Temperature 89 5.3.2 Temperature-dependent Case 89 5.3.3 Temperature-independent Case 89 5.3.4 Screw Design 90 5.3.5 Screw Speed 90 5.3.6 Feed-rate 91 5.4 Case Study 91 5.4.1 Matrix-assisted Co-crystallisation of Carbamazepine-Nicotinamide System by Twin-screw Extrusion 91 5.4.2 Avoiding Thermal Degradation of Carbamazepine through In Situ Co-crystallising with Nicotinamide 92 5.5 Conclusions 93 References 93 x

Contents 6 Taste Masking of Bitter Active Pharmaceutical Ingredients for the Development of Paediatric Medicines via Continuous Hot-Melt Extrusion Processing 97 6 Introduction 97 6.1 Hot-Melt Extrusion as an Active Taste Masking Technique 97 6.1.1 Taste Masking via Continuous Hot-Melt Extrusion Process 97 6.1.2 Polymers as Suitable Carriers for Taste Masking 99 6.1.3 Use of Lipids as Carriers for Taste Masking in Hot-Melt Extrusion 104 6.2 Continuous Manufacturing of Oral Films via Hot-Melt Extrusion 105 6.2.1 Case Study: Taste Masking of Bitter Active Pharmaceutical Ingredients via Continuous Hot-Melt Extrusion Processing 106 6.3 Materials 107 6.3.1 In Vivo Taste Masking Evaluation 107 6.3.2 In Vitro Taste Masking Evaluation: Astree e-tongue 107 6.3.3 Sample Preparation for Astree e-tongue 108 6.4 Results and Discussion 108 6.4.1 In Vivo/In Vitro Taste Evaluations Ill 6.5 Conclusions 115 References 115 7 Continuous Manufacturing of Pharmaceutical Products via Melt Extrusion: A Case Study 121 7 Introduction 121 Case Study 122 7.1 Materials and Method 122 7.1.1 Materials 122 7.1.2 Preparation of Formulation Blends and Continuous Hot-Melt Extrusion Processing 122 7.1.3 Scanning Electron Microscopy/Energy Dispersive X-ray Analysis 123 XI

Practical Guide to Hot-Melt Extrusion: Continuous Manufacturing and Scale-up 7.1.4 Thermal Analysis 123 7.1.5 Powder X-ray Diffraction 124 7.1.6 In Vitro Drug Release Studies 124 7.1.7 Analysis of Drug Release Mechanism 124 7.2 Results and Discussion 126 7.2.1 Continuous Manufacturing of Pellets via Hot-Melt Extrusion 127 7.2.2 Advanced Surface Analysis 129 7.2.4 Thermal Analysis 130 7.2.5 Amorphicity Analysis 131 7.2.6 In Vitro Dissolution Studies 132 7.2.7 Analysis of Release Mechanism 133 7.3 Conclusions 135 References 136 8 Novel Pharmaceutical Formulations Using Hot-Melt Extrusion Processing as a Continuous Manufacturing Technique 139 8 Introduction 139 8.1 Materials and Methods 140 8.1.1 Materials 140 8.1.2 Hot-Melt Extrusion Processing 140 8.1.3 Differential Scanning Calorimetry Analysis 140 8.1.4 Hot Stage Microscopy Analysis 140 8.1.5 X-ray Powder Diffraction 141 8.1.6 In Vitro Drug Release Studies 141 8.1.7 High-performance Liquid Chromatography Analysis 141 8.2 Results and Discussion 142 8.2.1 Hot-Melt Extrusion Processing 142 8.2.2 Thermal Analysis 142 8.2.3 X-ray Powder Diffraction Analysis 144 8.2.4 In Vitro Dissolution Studies 145 8.3 Conclusions 146 References 147 xii

Contents 9 Continuous Polymorphic Transformations Study via Hot-Melt Extrusion Process 149 9 Background 149 9.1 Polymorphism 149 9.2 Case Study: Polymorphic Transformation of Paracetamol 150 9.2.1 Experimental Methods 151 9.2.2 Theoretical Calculation 151 9.2.3 Continuous Hot-Melt Extrusion Process and In-line Monitoring 152 9.2.4 Thermal Analysis 153 9.3 Results and Discussion 154 9.3.1 Continuous Extrusion Process and Theoretical Consideration 154 9.3.2 Physicochemical Characterisation of the Polymorphic Transformation during Hot-Melt Extrusion 156 9.3.3 In-line Near-infrared Spectroscopy Monitoring 163 9.4 Conclusions 165 References 165 10 From Pharma Adapted Extrusion Technology to Brand New Pharma Fitted Extrusion Design: The Concept of Micro-scale Vertical Extrusion and its' Impact in Terms of Scale-up Potential 169 10 Introduction 169 10.1 The Advantages of Hot-Melt Extrusion 170 10.1.1 Examples of Problems Solved Thanks to Hot-Melt Extrusion 170 10.2 From Micro-scale to Industrial-scale 171 10.2.1 Viscosity of the Three Samples at Different Temperatures 172 10.2.2 Viscosity at Various Temperatures 173 10.3 Hot-Melt Extrusion as a Standard Technology for the Pharmaceutical Industry 174 10.4 Innovations 175 xni

Practical Guide to Hot-Melt Extrusion: Continuous Manufacturing and Scale-up 10.5 Conclusions 179 References 179 11 Continuous Manufacturing via Hot-Melt Extrusion and Scale-up: Regulatory Aspects 181 11 Introduction 181 11.1 Continuous Manufacturing and Hot-Melt Extrusion Processing Technology 181 11.2 Aspects of the Controls/Parameters in Hot-Melt Extrusion Processing 184 11.3 Continuous Manufacturing via Hot-Melt Extrusion 185 11.4 Continuous Manufacturing Process over Batch Process 187 11.5 Scale-up Methodologies 188 11.6 Regulatory Aspects 191 11.7 Summary 193 References 193 Abbreviations 197 Index 201 xiv